Balance Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Buy
269
+46
+21% +$47K 0.09% 125
2026
Q1
$205K Buy
223
+34
+18% +$34.5K 0.06% 145
2025
Q4
$203K Sell
189
-122
-39% -$117K 0.07% 140
2025
Q3
$238K Sell
311
-62
-17% -$46.1K 0.06% 125
2025
Q2
$291K Buy
373
+34
+10% +$26.4K 0.17% 88
2025
Q1
$280K Buy
+339
New +$282K 0.18% 95

Other funds holding LLY

Balance Wealth's LLY Position: Q2 2026 in Review

Balance Wealth increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $47K and bringing the position to 269 shares worth $323K. The position accounts for 0.09% of the portfolio, ranked #125.

Balance Wealth first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Balance Wealth held 269 shares of Eli Lilly worth $323K as of Q2 2026.
  • Balance Wealth bought 46 Eli Lilly shares in Q2 2026, an estimated $47K.
  • Eli Lilly made up 0.09% of Balance Wealth's portfolio in Q2 2026, its #125 holding.
  • Balance Wealth first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Balance Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.